Safety and Tolerability Extension Trial for Patients With Chronic Idiopathic Constipation

NCT01895543 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

411

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Idiopathic Constipation

Interventions

DRUG: Elobixibat 10 mg

Sponsor

Ferring Pharmaceuticals